Goepfert H, Jesse R H, Fletcher G H, Hamberger A
Laryngoscope. 1975 Jan;85(1):14-32. doi: 10.1288/00005537-197501000-00002.
The charts of 431 patients with squamous cell carcinoma of the supraglottic larynx observed at the M.D. Anderson Hospital between January, 1954, and June, 1971, were analyzed. This study is concerned with those patients who had a technically resectable lesion. Emphasis is directed to the analysis of the effectiveness of primary irradiation instead of partial laryngectomy for those lesions which are technically suitable for a partial resection and to define the groups of patients which are best treated by combining surgery and planned postoperative irradiation. One hundred forty-seven patients with T1 and T2 lesions, selected exophytic T3 lesions of the suprahyoid epiglottis received irradiation for their laryngeal lesion. A satisfactory control of the laryngeal disease has been obtained with preservation of a normal voice ranging from 88.5 percent for T1 lesions to 60 percent for T4 lesion. Comparing the groups of patients who had surgery alone or postoperative irradiation an NED rate of 63 percent was found in the latter group which is clearly superior to the 37 percent found in the surgery only group. There is no difference for the five-year NED rates, because the patients who had surgery and postoperative irradiation had more advanced neck disease which is a cause for distant metastases. The incidence of recurrences above the clavicles is clearly less in patients having had surgery and postoperative irradiation than in those who had surgery alone. Correlating in the two groups, surgery only and surgery followed by planned irradiation, the surgical staging of the neck metastases with recurrences above the clavicles within 24 months after treatment, it was found that the planned combined treatment has reduced the recurrence rate from 45 percent to 15 percent in the N2 and N3 patients. Postoperative irradiation should be given routinely after resection for all T4 lesions and for any T3 lesion which extends to the pharyngeal wall(s), vallecula, base of tongue, and pyriform sinus. Postoperative irradiation should also be given for any patient whose nodal classification is greater than N1. Irradiation should be given within six weeks (preferably three to four weeks) after the surgical procedure. To achieve this goal, the operation need only remove grossly detectable disease.
对1954年1月至1971年6月间在MD安德森医院观察的431例声门上型喉鳞状细胞癌患者的病历进行了分析。本研究关注那些病变在技术上可切除的患者。重点在于分析对于那些在技术上适合部分切除的病变,采用根治性放疗而非部分喉切除术的有效性,并确定最适合通过手术联合计划性术后放疗进行治疗的患者群体。147例T1和T2病变患者、舌骨上会厌的外生性T3病变患者接受了喉部病变的放疗。喉部疾病得到了满意的控制,声音得以保留,T1病变患者的保留率为88.5%,T4病变患者为60%。比较单纯手术组和术后放疗组患者,术后放疗组的无病生存率(NED)为63%,明显高于单纯手术组的37%。五年NED率没有差异,因为接受手术和术后放疗的患者颈部疾病更严重,这是远处转移的一个原因。接受手术和术后放疗的患者锁骨上方复发的发生率明显低于单纯手术的患者。在单纯手术组和手术加计划性放疗组这两组中,将颈部转移灶的手术分期与治疗后24个月内锁骨上方的复发情况相关联,发现计划性联合治疗使N2和N3患者的复发率从45%降至15%。对于所有T4病变以及任何延伸至咽壁、会厌谷、舌根和梨状窦的T3病变,切除术后应常规进行术后放疗。对于任何淋巴结分类大于N1的患者也应进行术后放疗。放疗应在手术程序后六周内(最好是三到四周)进行。为实现这一目标,手术只需切除肉眼可见的病变。